Despite the “non-specific” (no consideration of PSA expression) predictivity is lower than the specific one of PSA-expressing exosomes, it allows for a very considerable predictive power that could be useful for a future ‘first-level screening’ of general cancer risk or cancer staging. The gene discussed is KLK3; the disease is cancer.